These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9587132)

  • 1. Mass screening for neuroblastoma targeting children age 14 months in Sapporo City: a preliminary report.
    Nishi M; Miyake H; Takeda T; Hanai J; Kikuchi Y; Hirama T
    Cancer; 1998 May; 82(10):1973-7. PubMed ID: 9587132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass screening of neuroblastoma in Sapporo City, Japan.
    Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
    Berthold F; Baillot A; Hero B; Schurr P; Nerenz A; Hunneman DH; Sander J
    J Clin Oncol; 1999 Apr; 17(4):1200. PubMed ID: 10561179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass screening for neuroblastoma in Miyagi Prefecture.
    Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
    Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J
    J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
    Takeda T; Shimada M; Iizuka S; Takasugi N
    Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass screening for neuroblastoma and mortality in birth cohorts.
    Nishi M; Miyake H; Takeda T; Hanai J; Kikuchi Y; Takasugi N
    Int J Cancer; 1997 May; 71(4):552-5. PubMed ID: 9178807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
    Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
    J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cases of neuroblastoma missed by the mass screening programs.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J; Kawai T
    Pediatr Res; 1989 Dec; 26(6):603-7. PubMed ID: 2602040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese experience of screening.
    Takeda T; Hatae Y; Nakadate H; Nishi M; Hanai J; Sato Y; Takasugi N
    Med Pediatr Oncol; 1989; 17(5):368-72. PubMed ID: 2796852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
    Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
    Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
    Suita S
    J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to detect dopaminergic neuroblastoma in a mass-screening system.
    Naito H; Takeda T; Hanai J
    J Pediatr Surg; 1995 Sep; 30(9):1317-8. PubMed ID: 8523234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR; Gregory D; Bernstein M; Clow CL; Weisdorf T; Dougherty GE; Auray-Blais C; Giguère R; Lemieux B; Laberge C
    CMAJ; 1987 May; 136(9):952-6. PubMed ID: 3105859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for neuroblastoma in North America. 2-year results from the Quebec Project.
    Woods WG; Tuchman M; Bernstein ML; Leclerc JM; Brisson L; Look T; Brodeur GM; Shimada H; Hann HL; Robison LL
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):312-9. PubMed ID: 1456396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
    Kerbl R; Urban CE; Ladenstein R; Schnellauf C; Sitzwohl C; Lackner H; Gleispach H; Fauler G; Ambros PF; Ambros IM; Rumpler S; Gadner H; Spuller E; Höfler G; Amann G; Kytir J; Mutz I
    Wien Klin Wochenschr; 1996; 108(13):398-403. PubMed ID: 8766424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass screening for neuroblastoma in infants.
    Wei M; Ye M; Dong K; Dong R
    Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.